Abiraterone Acetate

CAS 154229-19-3 17 API suppliersSmall Molecule

Overview

Abiraterone Acetate is a steroidal compound used in the treatment of prostate cancer. It works by inhibiting the enzyme CYP17A1, which is involved in androgen production.

API suppliers (17)

Suppliers of Abiraterone Acetate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
China4India3France2Italy2Malta1Netherlands1USA1

Country recorded for 14 of 17 suppliers.

9 of 17 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

OncologyEndocrine Therapy
Verified Supplier Partner

Do you supply Abiraterone Acetate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.